Rempex Pharmaceuticals' Series B Round

Rempex Pharmaceuticals raised a round of funding on November 09, 2011.

Rempex Pharmaceuticals is a biopharmaceutical company that develops new therapies to combat the growing issue of antibiotic resistance. The company was founded to acquire all the assets, including fin…

Articles about Rempex Pharmaceuticals' Series B Round: